Y Intercept Hong Kong Ltd raised its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 185.9% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 18,828 shares of the exchange traded fund’s stock after acquiring an additional 12,242 shares during the period. Y Intercept Hong Kong Ltd’s holdings in SPDR S&P Biotech ETF were worth $1,887,000 as of its most recent SEC filing.
Other institutional investors also recently bought and sold shares of the company. DHJJ Financial Advisors Ltd. purchased a new stake in shares of SPDR S&P Biotech ETF during the second quarter valued at approximately $25,000. Capital A Wealth Management LLC purchased a new stake in SPDR S&P Biotech ETF during the 2nd quarter valued at $26,000. Johnson Financial Group Inc. purchased a new position in shares of SPDR S&P Biotech ETF in the second quarter worth $31,000. Twin Peaks Wealth Advisors LLC bought a new position in shares of SPDR S&P Biotech ETF during the second quarter valued at $32,000. Finally, Davis Capital Management purchased a new stake in shares of SPDR S&P Biotech ETF during the third quarter valued at $35,000.
SPDR S&P Biotech ETF Stock Performance
Shares of NYSEARCA:XBI opened at $126.74 on Friday. The business has a 50-day simple moving average of $123.61 and a two-hundred day simple moving average of $106.85. The firm has a market cap of $8.59 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a fifty-two week low of $66.66 and a fifty-two week high of $132.09.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Recommended Stories
- Five stocks we like better than SPDR S&P Biotech ETF
- America’s #1 Chaos Trader: “I’m so #&!$ bullish”
- Trump’s NEW Executive Order – BIG Changes Coming to Retirement Accounts
- The Crash Has Already Started (Most Just Don’t See It Yet)
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Nvidia CEO Issues Bold Tesla Call
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
